Hangzhou Biotest Biotech (688767.SS) Earnings Analysis
Hangzhou Biotest Biotech (688767.SS) has no confirmed upcoming earnings date. Trailing P/E 134.27.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 688767.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 688767.SS. This page updates as the calendar is published.
688767.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-27 | 0.23 CNY | n/a | n/a | n/a |
| 2025-10-30 | 0.06739 CNY | n/a | n/a | n/a |
688767.SS valuation and analyst view
| Trailing P/E | 134.27 |
|---|---|
| Trailing EPS | 0.19037 CNY |
| Price / book | 2.15 |
| Dividend yield | 2.01% |
| Market cap | 5.05B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Hangzhou Biotest Biotech (688767.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 688767.SS. This page updates as the calendar is published.
Did 688767.SS beat earnings last quarter?
Consensus estimate data was not available for 688767.SS's 2026-02-27 report.
What is 688767.SS's current P/E ratio and EPS?
688767.SS trades at a trailing P/E of 134.27 on trailing EPS of 0.19036876238929867 CNY.
What do analysts rate 688767.SS?
688767.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.